Trend Press Wire

Predictive Genetic Testing and Consumer Wellness Genomics Market:Worth $9 Bn by 2026

Press release   •   Nov 08, 2019 07:40 EST

The global ​Predictive Genetic Testing and Consumer Wellness Genomics Market is projected to grow at an annual rate of almost 13.2% over the forecast time frame 2019 to 2026, according to ARC. The global based market intelligence company expects the market to reach a value of around $9billion by 2026.

Acumen Research and Consulting has recently published a research report on the Predictive Genetic Testing and Consumer Wellness Genomics Market for the forecast period of 2019 to 2026, The report provides rational insights along with historical and forecast data that aids in better understanding of the global scenario of Predictive Genetic Testing and Consumer Wellness Genomics Market. The report provides a comprehensive analysis of the factors that are expected to drive and restrict the growth of the market. It also provides the detailed overview of the opportunities that are present in the market along with the current trends observed in the target market. The report includes a complete study of quantitative analysis of the industry for the period of 8 years in order to assist players to take advantage of the report. The report includes widespread analysis of the key segments of the industry that help for better understanding of the current trends and opportunities in this research report.

The Porters Five Forces analysis is included in the report, provides insights on the overall scenario from buyers and suppliers point-of-view. The regulatory compliances provide insight of the various government rules and regulations on various products and services and the way it affects the various end use industry.

Market Participants / Key Players:

The report cover the major players operating in the target market along with the key strategies adopted in order to get a competitive edge against the competitors which provides a competitive outlook of the industry. The report provides a competitive landscape that includes insights of the positioning of players on global level through mapping the business and product offering strength.

Several players, including Myriad Genetics, Inc 23andMe, Inc.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific, Inc.; Genesis Genetics; Abbott Laboratories; Agilent Technologies; BGI; Bio-Rad Laboratories Inc.; Counsyl, Inc.; Illumina, Inc.; and ARUP Laboratories. companies, research institutes, contract manufacturing organizations, and non-profit organizations, are playing a critical role in the development and production of these vectors.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1467

Scope of the Predictive Genetic Testing and Consumer Wellness Genomics Market Report:

The study provides a decisive view of the Predictive Genetic Testing and Consumer Wellness Genomics Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It also provides country wise segmentation and the factors that are driving the regional growth.

Market Segmentation:

By Test Type

  • Predictive Testing
  • Wellness Genomics
  • Consumer Genomics

By Application

  • Predictive Genetic Testing & Consumer Genomics

By Setting Type

  • Professional
  • DTC

By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Predictive Genetic Testing and Consumer Wellness Genomics Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global predictive genetic testing & consumer/wellness genomics market segments with market dynamics and their impact. The report also covers basic technology development policies.

This report provides an analysis of the latest trends in the industry in each sub-segment between 2015 and 2026 for a growth in revenues at the global, regional and national levels. In the context of that research, ARC segmented on a sample type, implementation, setting type and region as the worldwide predictive genetic test and consumer / goodness genomics market report:

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

  • What is the overall structure of the market?
  • What was the historical value and what is the forecasted value of the market?
  • What are the key product level trends in the market?
  • What are the market level trends in the market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the market space?

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Predictive Genetic Testing and Consumer Wellness Genomics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Predictive Genetic Testing and Consumer Wellness Genomics Market By Test Type
1.2.2.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
1.2.2.2. Global Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share By Test Type in 2018
1.2.2.3. Predictive Testing
1.2.2.3.1. Genetic Susceptibility Test
1.2.2.3.2. Predictive Diagnostics
1.2.2.3.3. Population Screening
1.2.2.4. Wellness Genomics
1.2.2.5. Consumer Genomics
1.2.2.5.1. Nutria Genetics
1.2.2.5.2. Skin & Metabolism Genetics
1.2.2.5.3. Other
1.2.3. Predictive Genetic Testing and Consumer Wellness Genomics Market By Application
1.2.3.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate Comparison By Application (2015- 2026)
1.2.3.2. Predictive Genetic Testing & Consumer Genomics
1.2.3.2.1. Breast & Ovarian Cancer
1.2.3.2.2. Cardiovascular screening
1.2.3.2.3. Diabetic Screening & Monitoring
1.2.3.2.4. Colon Cancer
1.2.3.2.5. Parkinsonism / Alzheimer’s Disease
1.2.3.2.6. Urologic screening/ Prostate cancer screening
1.2.3.2.7. Orthopedic & Musculoskeletal
1.2.3.2.8. Other cancer screening
1.2.3.2.9. Other
1.2.4. Predictive Genetic Testing and Consumer Wellness Genomics Market By Setting Type
1.2.4.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate Comparison By Setting Type (2015-2026)
1.2.4.2. Professional
1.2.4.3. DTC
1.2.5. Predictive Genetic Testing and Consumer Wellness Genomics Market by Geography
1.2.5.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Predictive Genetic Testing and Consumer Wellness Genomics Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Predictive Genetic Testing and Consumer Wellness Genomics Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Predictive Genetic Testing and Consumer Wellness Genomics Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Predictive Genetic Testing and Consumer Wellness Genomics Major Manufacturers in 2018

CHAPTER 4. PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY TEST TYPE

4.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Revenue By Test Type
4.2. Predictive Testing
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Genetic Susceptibility Test
4.2.4. Predictive Diagnostics
4.2.5. Population Screening
4.3. Wellness Genomics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Consumer Genomics
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4.3. Nutria Genetics
4.4.4. Skin & Metabolism Genetics
4.4.5. Other

CHAPTER 5. PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY APPLICATION
5.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Revenue By Application
5.2. Predictive Genetic Testing & Consumer Genomics
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. Breast & Ovarian Cancer
5.2.4. Cardiovascular screening
5.2.5. Diabetic Screening & Monitoring
5.2.6. Colon Cancer
5.2.7. Parkinsonism / Alzheimer’s Disease
5.2.8. Urologic screening/ Prostate cancer screening
5.2.9. Orthopedic & Musculoskeletal
5.2.10. Other cancer screening
5.2.11. Other

CHAPTER 6. PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY SETTING TYPE
6.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Revenue By Setting Type
6.2. Professional
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. DTC
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
7.1. North America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
8.1. Europe Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
9.1. Asia-Pacific Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
10.1. Latin America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
11.1. Middle East Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
12.1. Africa Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. Myriad Genetics
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Inc 23andMe, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. F. Hoffmann-La Roche Ltd.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Thermo Fisher Scientific, Inc.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Genesis Genetics
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Abbott Laboratories
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Agilent Technologies
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. BGI
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Bio-Rad Laboratories Inc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Counsyl, Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Illumina, Inc.
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. ARUP Laboratories.
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
13.13. Others
13.13.1. Company Snapshot
13.13.2. Overview
13.13.3. Financial Overview
13.13.4. Type Portfolio
13.13.5. Key Developments
13.13.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1467

Contact Us:

Acumen Research and Consulting

Email: sales@acumenresearchandconsulting.com

Phone: +1 407 915 4157

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.